Nested Therapeutics
Latest round
- Series A
Last raised
- Apr 2022
Total raised
- $50M
Investors
- 6
About Nested Therapeutics
Founded in 2021 by Klaus Hoeflich, Kevan Shokat, and Arvin Dar, and based in Massachusetts, US, Nested Therapeutics, Inc. operates as a biotech company that develops medicines for cancer treatment. In April 2022, Nested Therapeutics, Inc. In April 2022, Nested Therapeutics, Inc. The firm leverages genomics, computational biophysics, machine learning, and chemical biology to tap mutational clusters and offers a drug discovery platform that creates precision medicines to treat cancers and tumors.
Who invested in Nested Therapeutics
6 investors across 1 round
See all investors in Nested Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Apr 21, 2022
Amount
$50M
Investors
Questions about Nested Therapeutics
Who invested in Nested Therapeutics?
Nested Therapeutics has 6 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Nested Therapeutics raised?
Nested Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Nested Therapeutics last raise money?
Nested Therapeutics's most recent round on record is a Series A, in Apr 2022.
What does Nested Therapeutics do?
Founded in 2021 by Klaus Hoeflich, Kevan Shokat, and Arvin Dar, and based in Massachusetts, US, Nested Therapeutics, Inc.
Where is Nested Therapeutics headquartered?
Nested Therapeutics is headquartered in Cambridge, US.
Which VCs invest in companies like Nested Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Nested Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Nested Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.